Latest Pharmaceuticals policy Stories

Consumer Reports: So Many Drugstores, So Many Prices; New Report Finds Price Mayhem At The Pharmacy

2013-03-28 08:24:15

Tips for getting the best prices when you shop at the pharmacy; plus, why it pays to shop like a country mouse YONKERS, N.Y., March 28, 2013 /PRNewswire-USNewswire/ -- Consumers who don't shop around for their prescription drugs may be overpaying BIG time, explains Consumer Reports in its May issue. Failing to comparison shop could result in overpaying by as much as $100 a month or even more, depending on the drug. Consumer Reports compared drug prices for five blockbuster...

ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan

2013-03-27 20:23:37

FORT WASHINGTON, Pa. and TOKYO, March 27, 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services Inc. ("RPS"), a leading global contract research organization (CRO), and Asklep Inc. ("Asklep"), one of Japan's largest CROs, today announced the creation of a Joint Venture Company (JVC) to deliver leading-edge R&D outsourcing solutions in Japan to the biopharmaceutical and medical device industries. The exclusive RPS-Asklep collaboration will leverage RPS' proprietary structures...

Doing Business in China: Research on Chinese Good Manufacturing Practice Regulations for Medical Devices

2013-03-27 16:27:58

FARMINGTON, Conn., March 27, 2013 /PRNewswire-iReach/ -- As the world's largest population, prospects for medical device spending in China is huge. Government healthcare reforms are a major driving force behind China's healthcare sector. Not only are these policies instrumental for improving the healthcare system in China, but they also create significant market opportunities for companies in the lucrative Chinese medical devices market. The medical device market in China was valued...

Rising Medical Solutions Speaks on Technology that's Curbing the Rx Epidemic

2013-03-27 08:31:22

National Rx Drug Abuse Summit Spotlights Companies & People Making an Impact CHICAGO, March 27, 2013 /PRNewswire/ -- The prescription drug epidemic continues to take lives in America, causing 100 overdose deaths daily, according to the Centers for Disease Control and Prevention. It's an epidemic that does not discriminate, wrecking havoc on big cities and small towns alike, striking our youth and aging population. (Logo: http://photos.prnewswire.com/prnh/20080206/AQW030LOGO-b) For...

New PCMA Ad Campaign: 'It's the Oklahoma Drugstore Lobby vs. Employers'

2013-03-26 12:29:08

New Regulations Could Increase Prescription Drug Costs $1.7 Billion WASHINGTON, March 26, 2013 /PRNewswire-USNewswire/ -- As the Oklahoma drugstore lobby launches new attacks seeking to undermine tools used by pharmacy benefit managers (PBMs) to lower prescription drug costs, the Pharmaceutical Care Management Association (PCMA) released a new ad campaign defending the rights of employers to reduce wasteful pharmacy spending. As the ad says, employers think, "It's wrong" for the...

Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA

2013-03-25 20:21:58

Self-identifies as a Biopharmaceutics Classification System (BCS), Bioequivalence, and Bioavailability Testing Facility EXTON, Pa., March 25, 2013 /PRNewswire/ -- The preclinical contract research organization Absorption Systems, a global leader in pharmacokinetic testing of drugs and the world leader in the in-vitro classification of drugs according to the Biopharmaceutics Classification System (BCS), announces that it has registered with the United States Food and Drug...

PRA Voted "Best CRO" in Asia

2013-03-25 16:25:16

Awarded at BioPharma Asia Industry Awards 2013 RALEIGH, N.C., March 25, 2013 /PRNewswire/ -- PRA, a leading clinical research organization, today announced it was voted "Best CRO" for the 3(rd) annual BioPharma Asia Industry Awards 2013. The winner was announced March 19 at an awards dinner in Singapore. "We are deeply honored to have been voted 'Best CRO'," said Kent Thoelke, PRA executive vice president, Scientific and Medical Affairs. "We have been working hard to continually...

Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commission's case in FTC v. Actavis Inc.

2013-03-25 12:27:09

New White Paper from Paul Bender questions parallel legislative efforts in the Senate WASHINGTON, March 25, 2013 /PRNewswire-USNewswire/ -- On the day the U.S. Supreme Court hears oral arguments in FTC v. Actavis, a case that challenges the rights of brand-name and generic drug manufacturers to settle patent litigation out of court, Paul Bender, who served as Principal Deputy Solicitor General under President Bill Clinton, has released a new white paper on the topic. Bender,...

Sihuan Pharmaceutical Announces 2012 Annual Results

2013-03-25 04:22:14

- Revenue and Net Profit Surged 35.7% and 9.8%, Respectively - HONG KONG, March 25, 2013 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription drug market, today announced its annual results for the year ended 31 December 2012. Financial Highlights...

Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec

2013-03-22 08:24:29

NANJING, China, March 22, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Chinese SFDA has issued its approval for GMP certification of the influenza vaccine production facility at Jiangsu Simcere Vaxtec Bio-Pharmaceutical Co., Ltd ("Simcere Vaxtec"), a subsidiary in...